Boyar Asset Management Inc. Buys 46,366 Shares of Kenvue Inc. $KVUE

Boyar Asset Management Inc. raised its stake in shares of Kenvue Inc. (NYSE:KVUE) by 156.2% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 76,048 shares of the company’s stock after buying an additional 46,366 shares during the period. Boyar Asset Management Inc.’s holdings in Kenvue were worth $1,234,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently modified their holdings of the company. Salomon & Ludwin LLC bought a new stake in shares of Kenvue in the third quarter worth $25,000. NBT Bank N A NY lifted its holdings in Kenvue by 180.3% in the third quarter. NBT Bank N A NY now owns 1,564 shares of the company’s stock valued at $25,000 after acquiring an additional 1,006 shares during the period. Cornerstone Planning Group LLC lifted its holdings in Kenvue by 705.2% in the third quarter. Cornerstone Planning Group LLC now owns 1,554 shares of the company’s stock valued at $25,000 after acquiring an additional 1,361 shares during the period. Golden State Wealth Management LLC boosted its position in Kenvue by 150.1% in the third quarter. Golden State Wealth Management LLC now owns 1,983 shares of the company’s stock worth $32,000 after purchasing an additional 1,190 shares during the last quarter. Finally, Trust Co. of Vermont boosted its position in Kenvue by 50.9% in the third quarter. Trust Co. of Vermont now owns 2,385 shares of the company’s stock worth $39,000 after purchasing an additional 804 shares during the last quarter. 97.64% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several equities research analysts have recently commented on KVUE shares. Jefferies Financial Group lowered shares of Kenvue from a “buy” rating to a “hold” rating and reduced their price target for the company from $23.00 to $18.00 in a research report on Friday, January 30th. Zacks Research raised shares of Kenvue from a “strong sell” rating to a “hold” rating in a report on Wednesday, November 26th. UBS Group boosted their target price on shares of Kenvue from $17.00 to $19.00 and gave the company a “neutral” rating in a research report on Wednesday, February 18th. Argus raised shares of Kenvue to a “hold” rating in a report on Friday, March 6th. Finally, Canaccord Genuity Group increased their price target on shares of Kenvue from $17.00 to $18.00 and gave the stock a “hold” rating in a research report on Wednesday, February 18th. Three analysts have rated the stock with a Buy rating and thirteen have given a Hold rating to the company’s stock. According to MarketBeat.com, Kenvue presently has an average rating of “Hold” and an average target price of $19.58.

Kenvue Stock Up 0.3%

NYSE KVUE opened at $17.77 on Wednesday. Kenvue Inc. has a 52 week low of $14.02 and a 52 week high of $25.17. The company has a quick ratio of 0.68, a current ratio of 0.96 and a debt-to-equity ratio of 0.66. The company has a market capitalization of $34.05 billion, a P/E ratio of 23.07, a price-to-earnings-growth ratio of 4.02 and a beta of 0.51. The stock’s 50-day moving average price is $17.93 and its 200-day moving average price is $17.23.

Kenvue (NYSE:KVUE) last announced its quarterly earnings data on Tuesday, February 17th. The company reported $0.27 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.22 by $0.05. The company had revenue of $3.78 billion during the quarter, compared to the consensus estimate of $3.68 billion. Kenvue had a return on equity of 19.72% and a net margin of 9.72%.The firm’s revenue was up 3.2% on a year-over-year basis. During the same period in the previous year, the company posted $0.26 EPS. On average, equities research analysts predict that Kenvue Inc. will post 1.14 earnings per share for the current year.

Kenvue Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Wednesday, February 25th. Shareholders of record on Wednesday, February 11th were given a $0.2075 dividend. This represents a $0.83 dividend on an annualized basis and a dividend yield of 4.7%. The ex-dividend date was Wednesday, February 11th. Kenvue’s dividend payout ratio is presently 107.79%.

Kenvue Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.